Although overshadowed by the takeover offer, Dropsuite’s Q4 FY2024 were surprisingly strong and pleasing.

A takeover offer has driven the share price up by 30%.

China’s open-source AI may trash the business case of AI companies.

.

Great company, but plenty of growth already priced in.

AFG shares boast a P/E ratio under 15 times, a grossed up dividend yield of over 7.4%, and potential for growth.

Inflation moderated to 2.8% at year’s close but rents rose by 4.8%.

Microloans-for-poverty entrepreneur to face fraud trial in New York.

The Genetic Signatures (ASX: GSS) share price suffers from its lack of profitability, but the diagnostic testing company may be on the verge of substantial growth.

Hundred million-dollar investment provides intermediate care option between GPs and emergency room.

.

It is not obviously cheap but it is obviously taking market share from its competitors.

Zuckerberg signals pro-Trump shift in overnight speech.

Family allege foul play after San Francisco authorities judge death to be suicide.

.

Do grown-ups find it threatening that children would possess genius? If the role of the artist is to offer a new perspective to ponder, surely a child could do this too.

It was a good year with a hypothetical equally weighted portfolio of my recommendations gaining around 28% and my personal portfolio up over 40% (thanks to Pro Medicus once again).

The indigenous Australian medicine at the centre of multimillion-dollar price-fixing scandal.